These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 31117293)
1. The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells. Shalem-Cohavi N; Beery E; Nordenberg J; Rozovski U; Raanani P; Lahav M; Uziel O Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117293 [TBL] [Abstract][Full Text] [Related]
2. Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo. Weiss C; Uziel O; Wolach O; Nordenberg J; Beery E; Bulvick S; Kanfer G; Cohen O; Ram R; Bakhanashvili M; Magen-Nativ H; Shilo N; Lahav M Br J Cancer; 2012 Nov; 107(11):1844-52. PubMed ID: 23169337 [TBL] [Abstract][Full Text] [Related]
3. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells. Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Sinha-Datta U; Horikawa I; Michishita E; Datta A; Sigler-Nicot JC; Brown M; Kazanji M; Barrett JC; Nicot C Blood; 2004 Oct; 104(8):2523-31. PubMed ID: 15226182 [TBL] [Abstract][Full Text] [Related]
5. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317 [TBL] [Abstract][Full Text] [Related]
6. Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors. Bat-Erdene A; Miki H; Oda A; Nakamura S; Teramachi J; Amachi R; Tenshin H; Hiasa M; Iwasa M; Harada T; Fujii S; Sogabe K; Kagawa K; Yoshida S; Endo I; Aihara K; Abe M Oncotarget; 2016 Nov; 7(48):79064-79075. PubMed ID: 27738323 [TBL] [Abstract][Full Text] [Related]
7. ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma. Jiang J; Sun Y; Xu J; Xu T; Xu Z; Liu P Cancer Med; 2020 Oct; 9(19):7244-7252. PubMed ID: 32780537 [TBL] [Abstract][Full Text] [Related]
8. The cellular senescence of leukemia-initiating cells from acute lymphoblastic leukemia is postponed by β-Arrestin1 binding with P300-Sp1 to regulate hTERT transcription. Liu S; Liu H; Qin R; Shu Y; Liu Z; Zhang P; Duan C; Hong D; Yu J; Zou L Cell Death Dis; 2017 Apr; 8(4):e2756. PubMed ID: 28425985 [TBL] [Abstract][Full Text] [Related]
9. NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG₂ hepatoma cell line. Zuo QP; Liu SK; Li ZJ; Li B; Zhou YL; Guo R; Huang LH Eur J Pharmacol; 2011 Dec; 672(1-3):113-20. PubMed ID: 22008847 [TBL] [Abstract][Full Text] [Related]
10. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. Oh ST; Kyo S; Laimins LA J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963 [TBL] [Abstract][Full Text] [Related]
11. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription. Endoh T; Tsuji N; Asanuma K; Yagihashi A; Watanabe N Exp Cell Res; 2005 May; 305(2):300-11. PubMed ID: 15817155 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells. Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348 [TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-κB-dependent transcription. Ding D; Xi P; Zhou J; Wang M; Cong YS FASEB J; 2013 Nov; 27(11):4375-83. PubMed ID: 23884427 [TBL] [Abstract][Full Text] [Related]
15. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner. Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922 [TBL] [Abstract][Full Text] [Related]
16. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Jagadeesh S; Kyo S; Banerjee PP Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011 [TBL] [Abstract][Full Text] [Related]
17. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas. Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344 [TBL] [Abstract][Full Text] [Related]
18. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase. Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865 [TBL] [Abstract][Full Text] [Related]
19. Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells. Liu L; Liu C; Lou F; Zhang G; Wang X; Fan Y; Yan K; Wang K; Xu Z; Hu S; Björkholm M; Xu D J Pathol; 2011 Oct; 225(2):203-11. PubMed ID: 21590772 [TBL] [Abstract][Full Text] [Related]
20. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities. Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]